HDAC6 is required for invadopodia activity and invasion by breast tumor cells

被引:77
|
作者
Rey, Mercedes [1 ,2 ]
Irondelle, Marie [1 ,2 ]
Waharte, Francois [1 ,3 ]
Lizarraga, Floria [1 ,2 ]
Chavrier, Philippe [1 ,2 ]
机构
[1] Inst Curie, Res Ctr, F-75248 Paris 05, France
[2] CNRS, UMR144, F-75248 Paris 05, France
[3] Inst Curie, CNRS, Cell & Tissue Imaging Facil, PICT IBiSA,UMR 144, F-75248 Paris 05, France
关键词
Invadopodia; Acetylation; Histone deacetylase; HDAC6; Tumor cell invasion; EXTRACELLULAR-MATRIX DEGRADATION; IN-VIVO; BASEMENT-MEMBRANE; CONTACT SITES; CANCER; ACETYLATION; CORTACTIN; METALLOPROTEINASE; MICROTUBULES; DEACETYLASE;
D O I
10.1016/j.ejcb.2010.09.004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Invasion across tissue boundaries by metastatic tumor cells depends on the proteolytic degradation of the extracellular matrix, initiated by the formation of invadopodia, actin-driven membrane protrusions with matrix-degradative activity. Yet, mechanisms underlying invadopodia formation remain largely unknown. In this report, we examined the role of the histone deacetylase HDAC6 in invadopodia formation and invasion by breast cancer cells. Using small interfering RNA silencing of protein expression in highly invasive MDA-MB-231 breast adenocarcinoma cells, we show that HDAC6 is required for two-dimensional matrix proteolysis. In addition, we demonstrate that HDAC6 acts as a tubulin and cortactin deacetylase. We also report that the inhibition of HDAC6 by siRNA or treatment with HDAC inhibitor TSA results in a decreased invasion capacity of a three-dimensional type I collagen matrix by MDA-MB-231 cells. These data identify HDAC6 as a critical component of the invasive apparatus of tumor cells, in both two- and three-dimensional matrices. (C) 2010 Elsevier GmbH. All rights reserved.
引用
收藏
页码:128 / 135
页数:8
相关论文
共 50 条
  • [31] aPKC Phosphorylation of HDAC6 Results in Increased Deacetylation Activity
    Du, Yifeng
    Seibenhener, Michael L.
    Yan, Jin
    Jiang, Jianxiong
    Wooten, Michael C.
    PLOS ONE, 2015, 10 (04):
  • [32] HDAC6 Inhibition Restores Ciliary Expression and Decreases Tumor Growth
    Gradilone, Sergio A.
    Radtke, Brynn N.
    Bogert, Pamela S.
    Huang, Bing Q.
    Gajdos, Gabriella B.
    LaRusso, Nicholas F.
    CANCER RESEARCH, 2013, 73 (07) : 2259 - 2270
  • [33] Enhancing the effect of immunotherapy by inhibiting tumor promoting effect of HDAC6
    Banik, Debarati
    Beaty, Melissa
    Palmer, Erical
    Hernandez, Maria Del Mar Gracia
    Noonepalle, Satish K.
    Vembu, Prathima
    Kozikowski, Alan P.
    Villagra, Alejandro
    CANCER RESEARCH, 2019, 79 (13)
  • [34] Lysine Deacetylation by HDAC6 Regulates the Kinase Activity of AKT in Human Neural Progenitor Cells
    Iaconelli, Jonathan
    Lalonde, Jasmin
    Watmuff, Bradley
    Liu, Bangyan
    Mazitschek, Ralph
    Haggarty, Stephen J.
    Karmacharya, Rakesh
    ACS CHEMICAL BIOLOGY, 2017, 12 (08) : 2139 - 2148
  • [35] Targeting HDAC6 to reduce the aggressiveness of metastatic breast cancer in immunotherapy
    Banik, Debarati
    Hadley, Melissa
    Palmer, Erica
    Gallub, Vincent
    Sotomayor, Eduardo
    Kozikowski, Alan
    Villagra, Alejandro
    CANCER RESEARCH, 2018, 78 (13)
  • [36] Anti-metastatic activity of MPTOG211, a novel HDAC6 inhibitor, in human breast cancer cells in vitro and in vivo
    Hsieh, Yi-Ling
    Tu, Huang-Ju
    Pan, Shiow-Lin
    Liou, Jing-Ping
    Yang, Chia-Ron
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2019, 1866 (06): : 992 - 1003
  • [37] HDAC6 regulates neuroblastoma cell migration and may play a role in the invasion process
    Zhang, Linlin
    Liu, Ningning
    Xie, Songbo
    He, Xianfei
    Tala
    Zhou, Jun
    Liu, Min
    Li, Dengwen
    CANCER BIOLOGY & THERAPY, 2014, 15 (11) : 1561 - 1570
  • [38] HDAC6 inhibition enhances the anti-tumor effect of eribulin through tubulin acetylation in triple-negative breast cancer cells
    Oba, Takaaki
    Ono, Mayu
    Matoba, Hisanori
    Uehara, Takeshi
    Hasegawa, Yoshie
    Ito, Ken-ichi
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (01) : 37 - 51
  • [39] HDAC6 is required for epidermal growth factor-induced β-catenin nuclear localization
    Li, Yu
    Zhang, Xiaowu
    Polakiewicz, Roberto D.
    Yao, Tso-Pang
    Comb, Michael J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (19) : 12686 - 12690
  • [40] HDAC6 inhibition enhances the anti-tumor effect of eribulin through tubulin acetylation in triple-negative breast cancer cells
    Takaaki Oba
    Mayu Ono
    Hisanori Matoba
    Takeshi Uehara
    Yoshie Hasegawa
    Ken-ichi Ito
    Breast Cancer Research and Treatment, 2021, 186 : 37 - 51